ESC 365 - Renal denervation lowers all-cause and cardiovascular mortality in patients with uncontrolled arterial hypertension: a randomised, sham-controlled study.

ESC Professional Premium Access

Renal denervation lowers all-cause and cardiovascular mortality in patients with uncontrolled arterial hypertension: a randomised, sham-controlled study.

Session: Smaller trials, trial updates, and other studies on hypertension

Topic: Device Treatment

Speaker: Doctor M. Heradien (Kuils River, ZA)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Marshall Heradien

Kuils River (South Africa)

1 presentation

0 follower

4 more presentations in this session

Effects of Intensive vs Standard Blood Pressure Control on Cardiovascular Outcomes in Cancer Survivors: Results from the SPRINT Randomized Trial

Speaker: Doctor Y. Xiao (Changsha, CN)

A machine learning algorithm for personalizing intensive blood pressure treatment: derivation from SPRINT/ACCORD-BP trials and validation in CRHCP, a pragmatic implementation trial

Speaker: Professor Y. Sun (Shenyang, CN)

Long-term outcomes of intensive blood-pressure control in older patients with hypertension: final six-year results of the STEP trial

Speaker: Doctor Q. Song (Beijing, CN)

Fractional flow reserve to determine the appropriateness of percutaneous renal artery intervention in atherosclerotic renovascular hypertension patients: a randomized trial

Speaker: Professor J. Li (Beijing, CN)

Access the full session

Smaller trials, trial updates, and other studies on hypertension

Speakers: Doctor M. Heradien, Doctor Y. Xiao, Professor Y. Sun, Doctor Q. Song, Professor J. Li

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources